Evoke Pharma

EVOK NASDAQ
0.5614
-0.0286
-4.85%
已收盘, 16:00 06/25 EDT
开盘
0.5950
昨收
0.5900
最高
0.6195
最低
0.5500
成交量
30.12万
成交均量(3M)
65.42万
52周最高
3.400
52周最低
0.5300
换手率
1.30%
市值
1,305.91万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Evoke Pharma EVOK股票价格,Evoke Pharma股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. EVK-001 is a formulation of Metoclopramide drug, designed to provide systemic delivery of metoclopramide through intranasal administration. The Company has evaluated EVK-001 in a multicenter, randomized, double-blind, placebo-controlled parallel group, dose-ranging Phase IIb clinical trial. The Company has commenced a Phase III clinical trial of EVK-001 in female patients with symptoms associated with acute and recurrent diabetic gastroparesis. The Phase III clinical trial is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy, safety and population pharmacokinetics of EVK-001 in adult females.
展开 >

最近浏览

名称
价格
涨跌幅